Correction to 'Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir'

MLA

Carmay Lim, et al. “Correction to ‘Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.’” ACS Pharmacology & Translational Science, vol. 4, no. 3, Apr. 2021, p. 1246. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....83ed2b416edaa0ad381e925d768385f4&authtype=sso&custid=ns315887.

APA

Carmay Lim, Ting Chen, Yi-Ping Chen, Chun-Ping Chang, Karen Sargsyan, Cheng-Yin Fei, Yi-Ling Lin, Chun-Che Liao, Hanna S. Yuan, & Jian-Jong Liang. (2021). Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.” ACS Pharmacology & Translational Science, 4(3), 1246.

Chicago

Carmay Lim, Ting Chen, Yi-Ping Chen, Chun-Ping Chang, Karen Sargsyan, Cheng-Yin Fei, Yi-Ling Lin, Chun-Che Liao, Hanna S. Yuan, and Jian-Jong Liang. 2021. “Correction to ‘Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.’” ACS Pharmacology & Translational Science 4 (3): 1246. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....83ed2b416edaa0ad381e925d768385f4&authtype=sso&custid=ns315887.